Search results
Found 2376 matches for
Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.
Research
The Oxford Vaccine Group conducts laboratory and clinical research in many different areas related to infectious diseases and vaccination in childhood as well as adulthood. Below you can browse all the different areas we investigate.
Study with us
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.